Prelude Therapeutics
PRLD
#9185
Rank
NZ$0.12 B
Marketcap
$2.30
Share price
46.40%
Change (1 day)
-65.65%
Change (1 year)

EPS for Prelude Therapeutics (PRLD)

EPS in 2023 (TTM): -$3.51

According to Prelude Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.84. In 2022 the company made an earnings per share (EPS) of -$4.31 a decrease over its 2021 EPS that were of -$4.28.

EPS history for Prelude Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.51-18.58%
2022-$4.310.83%
2021-$4.28-61.3%
2020-$11.05

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.85 0.46%๐Ÿ‡บ๐Ÿ‡ธ USA